GSA Capital Partners »

Inozyme Pharma shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $711k 167k 4.26
2023-09-30 $389k 93k 4.20
2023-06-30 $149k 27k 5.56

More positions owned by GSA Capital Partners

Amazon (AMZN)
CRH Ord (CRH)
Remitly Global (RELY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Aon Shs Cl A (AON)
Magnite Ord (MGNI)
Zillow Group Cl A (ZG)
UnitedHealth (UNH)
Sprott Fds Tr Uranium Miners E (URNM)
Vanguard World Fds Health Car Etf (VHT)
Sba Communications Corp Cl A (SBAC)
Calavo Growers (CVGW)
Appfolio Com Cl A (APPF)
Star Bulk Carriers Corp. Shs Par (SBLK)
Bwx Technologies (BWXT)

View all positions for GSA Capital Partners

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma